ReviewFrontiers in immunology2021

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure.

Caroline Thue Hvilsom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.